DRD2 and schizophrenia: The dopamine hypothesis of schizophrenia has been one of the most enduring assumptions on the origin of the disease, based on the evidence of antipsychotics acting as D2R blockers, and considering the striatal dopamine hyperactivity as responsible for the occurrence of positive symptoms [35,67,68].